Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 27 Issue 5
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2009  >  27(5): 323-333,361

JIA Jing, LI Yue-yue, ZHU Zhen-yu, CHAI Yi-feng, ZHANG Guo-qing. Inhibition research of three commonly-used anti-tumor drugs against HepG2 cell line[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 323-333,361.
Citation: JIA Jing, LI Yue-yue, ZHU Zhen-yu, CHAI Yi-feng, ZHANG Guo-qing. Inhibition research of three commonly-used anti-tumor drugs against HepG2 cell line[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 323-333,361.
shu

Inhibition research of three commonly-used anti-tumor drugs against HepG2 cell line

  • 1.

    Department of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 2.

    Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China

  • Received Date: 2009-02-25
  • Objective :To establish an inhibition research method of three commonly-used anti-tumor drugs against HepG2 cell line. Methods : The determination was performed on a 96-well plate.The drugs were administrated in a series of concentrations,and each concentration was triplicate.Cells without drugs were set as a negative control.Followed by determination of MTT method,the inhibition ratio was plotted to concentration. Results :The inhibition ability of 3 drugs were different when the concentration were in different range.On the whole,the inhibition ability of 5-Fu was the weakest one. Conclusion :The method evaluates and compares the inhibition ability of 3 commonly-used anti-tumor drugs against HepG2 cell line,and could be a reference in positive control of drug screening experiment.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2180) PDF downloads(1413) Cited by()

Related
Proportional views

Inhibition research of three commonly-used anti-tumor drugs against HepG2 cell line

  • 1. Department of Pharmacy, Second Military Medical University, Shanghai 200433, China
  • 2. Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
  • Received Date: 2009-02-25

Abstract: Objective :To establish an inhibition research method of three commonly-used anti-tumor drugs against HepG2 cell line. Methods : The determination was performed on a 96-well plate.The drugs were administrated in a series of concentrations,and each concentration was triplicate.Cells without drugs were set as a negative control.Followed by determination of MTT method,the inhibition ratio was plotted to concentration. Results :The inhibition ability of 3 drugs were different when the concentration were in different range.On the whole,the inhibition ability of 5-Fu was the weakest one. Conclusion :The method evaluates and compares the inhibition ability of 3 commonly-used anti-tumor drugs against HepG2 cell line,and could be a reference in positive control of drug screening experiment.

JIA Jing, LI Yue-yue, ZHU Zhen-yu, CHAI Yi-feng, ZHANG Guo-qing. Inhibition research of three commonly-used anti-tumor drugs against HepG2 cell line[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 323-333,361.
Citation: JIA Jing, LI Yue-yue, ZHU Zhen-yu, CHAI Yi-feng, ZHANG Guo-qing. Inhibition research of three commonly-used anti-tumor drugs against HepG2 cell line[J]. Journal of Pharmaceutical Practice and Service, 2009, 27(5): 323-333,361.
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return